One in four patients requiring hemodialysis will die from access failure.

One in four patients

At Ariste, we are developing a new class of drug eluting devices that will offer improved performance over legacy products. Our technology will help prevent device failure, resulting in improved patient outcomes and reduced costs of care.

See how Ariste technology works

Surgical infection continues to cause unnecessary morbidity and mortality.

Surgical Infection

At Ariste, we are developing a new class of drug eluting devices that will offer improved performance over legacy products. Our technology will help prevent device failure, resulting in improved patient outcomes and reduced costs of care.

See how Ariste technology works

Restenosis is a common cause of device failure.

Blood clot

At Ariste, we are developing a new class of drug eluting devices that will offer improved performance over legacy products. Our technology will help prevent device failure, resulting in improved patient outcomes and reduced costs of care.

See how Ariste technology works

Our Technology

Ariste has developed a novel method of eluting drugs from the surface of ePTFE, the most slippery surface identified to date. Ariste’s technology will enable the development of a new class of drug-eluting devices that may improve patient outcomes in common vascular procedures, including hemodialysis access, peripheral bypass and hernia repair.

Ariste is presently developing a drug eluting vascular graft for hemodialysis access and a drug eluting tissue patch for hernia repair. Why is this important? Because ePTFE, better known as GoreTex, has been preferred materials for medical implants since the 1970’s...

More >

Latest News

More >

Contact Us

Find out more about Ariste Medical